Planet 13 Holdings (PLNH) Cash from Investing Activities (2021 - 2026)
Planet 13 Holdings (PLNH) reported Cash from Investing Activities of $854829.0 for Q1 2026, up 131.76% year-over-year from $368837.5 in Q1 2025, and down 57.58% quarter-over-quarter from $2.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Cash from Investing Activities data on file, last reported at $854829.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $854829.0, up 131.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (up 271.91% YoY), and the FY2025 annual result was $2.5 million, up 166.82% from the prior year.
- Cash from Investing Activities slipped to $854829.0 in Q1 2026 per PLNH's latest filing, from $2.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $5.5 million in Q3 2025 and troughed at -$7.7 million in Q2 2022.
- A 5-year average of -$1.4 million and a median of -$2.4 million in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities jumped 1206.36% in 2024, then sank 154.63% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$1.0 million in 2022, then plunged by 128.71% to -$2.4 million in 2023, then decreased by 8.44% to -$2.5 million in 2024, then surged by 179.05% to $2.0 million in 2025, then tumbled by 57.58% to $854829.0 in 2026.
- Business Quant data shows PLNH's Cash from Investing Activities at $854829.0 in Q1 2026, $2.0 million in Q4 2025, and $5.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | 854,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 854,829.00 |
| Mar 31, 2026 | 854,829.00 |
| Dec 31, 2025 | 2.01 Mn |
| Dec 31, 2025 | 2.01 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | -2.94 Mn |
| Mar 31, 2024 | -2.94 Mn |
| Dec 31, 2023 | -2.35 Mn |
| Dec 31, 2023 | -2.35 Mn |